Silo Pharma, Inc. (SILO)
About Silo Pharma, Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $72.1K
- Net income
- -$4.2M
- Total assets
- $7.6M
- Market cap
- $5.0M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.0M
- Shares outstanding
- 4.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 5, 2012
Silo Pharma, Inc. (SILO) Stock Price
- Reported a net loss of $4.2M in FY2025.
- Trading 90% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Silo Pharma, Inc..
Write a review
News about Silo Pharma, Inc.
News & sentiment via Polygon.io
Silo Pharma, Inc.: frequently asked questions
Is Silo Pharma, Inc. an American company?
Silo Pharma, Inc. is a US-based company headquartered in Sarasota, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Silo Pharma, Inc. headquartered?
Silo Pharma, Inc. is headquartered in Sarasota, Florida, United States.
Is Silo Pharma, Inc. publicly traded?
Yes — Silo Pharma, Inc. is a publicly traded company. Its stock trades under the ticker symbol SILO on the NASDAQ.
What does Silo Pharma, Inc. do?
Silo Pharma, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
